ABOUT US > AUA Governance > AUA Policies > Policy Statements > Diagnostic Evaluation of Erectile Dysfunction

Diagnostic Evaluation of Erectile Dysfunction

The American Urological Association, Inc.® (AUA) endorses the position statement of the Sexual Medicine Society of North America regarding the diagnostic evaluation of erectile dysfunction as follows:

"Diagnostic studies used to evaluate the pathophysiology of impotence should be individualized for each patient.

A generic or standard list of diagnostic tests for all patients is not an appropriate practice.

Studies used for the diagnostic evaluation of impotence should be limited in general to the tests which are needed to identify the treatment options available to each patient, taking into account each patient's unique clinical status and treatment preferences.

The patient who wishes to identify the cause or causes of his erectile dysfunction as organic and/or psychogenic, nocturnal penile tumescence and rigidity (NPTR) monitoring, vascular and other testing are useful, but the patient must be provided information permitting an informed decision to seek testing which is not essential to the selection of treatment options.

NPTR monitoring and extensive vascular testing are not indicated for the diagnostic evaluation of every impotent patient.

Ethical medical practice requires that diagnostic, therapeutic and other decisions must be made solely for the benefit of the patient and must be made without regard for the benefit of the healthcare provider."

Board of Directors, April 1997
Board of Directors, May 2002(Revised)
Board of Directors, May 2007 (Revised)
Board of Directors, May 2012 (Revised)

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT